Citadel Advisors’s Safeguard Scientifics, Inc. SFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-12,460
Closed -$21.4K 15538
2023
Q1
$21.4K Sell
12,460
-4,091
-25% -$11.3K ﹤0.01% 13019
2022
Q4
$51.3K Buy
+16,551
New +$55.6K ﹤0.01% 12104
2022
Q1
Sell
-38,230
Closed -$281K 14884
2021
Q4
$281K Sell
38,230
-62,733
-62% -$490K ﹤0.01% 11059
2021
Q3
$896K Buy
100,963
+19,222
+24% +$154K ﹤0.01% 8437
2021
Q2
$635K Buy
+81,741
New +$557K ﹤0.01% 9480
2020
Q3
Sell
-29,646
Closed -$208K 10935
2020
Q2
$208K Sell
29,646
-10,213
-26% -$64.6K ﹤0.01% 8478
2020
Q1
$221K Buy
39,859
+18,563
+87% +$166K ﹤0.01% 7849
2019
Q4
$234K Sell
21,296
-32,582
-60% -$372K ﹤0.01% 7964
2019
Q3
$611K Buy
53,878
+19,479
+57% +$232K ﹤0.01% 6420
2019
Q2
$415K Buy
+34,399
New +$403K ﹤0.01% 7089
2018
Q2
Sell
-19,643
Closed -$241K 9417
2018
Q1
$241K Sell
19,643
-4,551
-19% -$55.3K ﹤0.01% 7063
2017
Q4
$271K Sell
24,194
-31,383
-56% -$402K ﹤0.01% 6625
2017
Q3
$742K Sell
55,577
-541
-1% -$6.67K ﹤0.01% 4752
2017
Q2
$668K Buy
56,118
+35,609
+174% +$419K ﹤0.01% 4710
2017
Q1
$260K Buy
+20,509
New +$258K ﹤0.01% 6092
2016
Q3
Sell
-12,340
Closed -$154K 7913
2016
Q2
$154K Buy
+12,340
New +$166K ﹤0.01% 6014
2016
Q1
Sell
-24,112
Closed -$350K 8237
2015
Q4
$350K Buy
+24,112
New +$389K ﹤0.01% 4996
2014
Q3
Sell
-39,598
Closed -$823K 8486
2014
Q2
$823K Buy
39,598
+4,356
+12% +$87.6K ﹤0.01% 3751
2014
Q1
$782K Buy
+35,242
New +$700K ﹤0.01% 3743
2013
Q3
Sell
-30,977
Closed -$497K 6910
2013
Q2
$497K Buy
+30,977
New +$492K ﹤0.01% 3850

Other funds holding SFE

Citadel Advisors's SFE Position: Q2 2023 in Review

Citadel Advisors sold out of Safeguard Scientifics, Inc. (SFE) in Q2 2023, closing a stake of 12,460 shares — an estimated $21.4K sold.

Citadel Advisors first reported a position in SFE in Q2 2013 and held it in 20 quarters. The position peaked at $896K in Q3 2021. 45 funds tracked by Wall St. Rank hold SFE as of Q2 2023.

  • Citadel Advisors reported no remaining Safeguard Scientifics, Inc. position as of Q2 2023 after selling out during the quarter.
  • Citadel Advisors sold 12,460 Safeguard Scientifics, Inc. shares in Q2 2023, an estimated $21.4K.
  • Citadel Advisors first reported a position in Safeguard Scientifics, Inc. in Q2 2013 and held it in 20 quarters.
  • Citadel Advisors's Safeguard Scientifics, Inc. position peaked at $896K in Q3 2021.
  • 45 funds tracked by Wall St. Rank held Safeguard Scientifics, Inc. as of Q2 2023.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.